The Cooper Companies, Inc.
COO
Rangering i aksjer
#1935
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Aksjekurs
$57.43
Markedsverdi
$10.92B
Endring (1 dag)
-0.88%
Endring (1 år)
-20.20%
Land
US
Handel The Cooper Companies, Inc. (COO)
Kategori
Healthcare
EPS for The Cooper Companies, Inc. (COO)
EPS per July 2026 TTM: $2.93
Ifølge de siste økonomiske rapportene og aksjekursen til The Cooper Companies, Inc. er selskapets nåværende EPS (TTM) $2.93. Ved slutten av 2024 hadde selskapet en EPS på $1.97, en økning sammenlignet med EPS-en i 2023 som var $1.49.
EPS-historikk for The Cooper Companies, Inc. fra 2000 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $2.93 | 55.85% |
| 2025 | $1.88 | -4.57% |
| 2024 | $1.97 | 32.21% |
| 2023 | $1.49 | -23.98% |
| 2022 | $1.96 | -96.72% |
| 2021 | $59.73 | 1,129.01% |
| 2020 | $4.86 | -48.68% |
| 2019 | $9.47 | 232.28% |
| 2018 | $2.85 | -62.65% |
| 2017 | $7.63 | 35.04% |
| 2016 | $5.65 | 34.52% |
| 2015 | $4.20 | -25.13% |
| 2014 | $5.61 | -7.88% |
| 2013 | $6.09 | 17.57% |
| 2012 | $5.18 | 38.50% |
| 2011 | $3.74 | 50.81% |
| 2010 | $2.48 | 11.21% |
| 2009 | $2.23 | 52.74% |
| 2008 | $1.46 | -684.00% |
| 2007 | $-0.25 | -116.78% |
| 2006 | $1.49 | -27.67% |
| 2005 | $2.06 | -27.21% |
| 2004 | $2.83 | 28.64% |
| 2003 | $2.20 | 37.50% |
| 2002 | $1.60 | 28.00% |
| 2001 | $1.25 | 22.55% |
| 2000 | $1.02 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $8.85 | 202.05% |
US
|
|
| $6.41 | 118.61% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 13.31% |
US
|
|
| - | - |
CH
|
